Arie Belldegrun - Mar 14, 2022 Form 4/A - Amendment Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/ Veer Bhavnagri, Attorney-in-Fact for Arie Belldegrun
Stock symbol
ALLO
Transactions as of
Mar 14, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
4/1/2022, 05:40 PM
Date Of Original Report
Mar 31, 2022
Previous filing
Jan 14, 2022
Next filing
Mar 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Other $0 -4.71M -100% $0.00* 0 Mar 14, 2022 See footnote F2
transaction ALLO Common Stock Other $0 +4.71M $0.00 4.71M Mar 14, 2022 See footnote F1, F2
holding ALLO Common Stock 372K Mar 14, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct the share holdings reported on the Form 4 filed by the reporting person on March 31, 2022.
F2 These shares were sold by Bellco Legacy IV LLC, of which the reporting person and Rebecka Belldegrun are managers, to Bellco Legacy Trust fbo Rebecka Belldegrun, of which the reporting person's spouse is trustee and beneficiary. In exchange for the shares, the reporting person received a promissory note in the principal amount of $36,032,418.00.